Home
thosc49

Thomas Schön

Professor

My research concerns individualized treatment and improved diagnostics for tuberculosis and other infectious diseases.

Research focused on tuberculosis

My research is mainly focused on tuberculosis which causes about 10 million new cases per year of which about 1 million die. The immune system, bacterial resistance mechanisms to treatment and antibiotic dosing are important factors that partly determine who gets sick and who does not, but also how successful the treatment will be.

Several of my research projects in both Sweden and Ethiopia concern individualized treatment and improved diagnostics for tuberculosis and other infectious diseases, with the aim of improving the resilience of the immune system and streamlining treatment.

News

vaccination.

SEK 15 million for research into Covid-19 vaccination

A research project coordinated by LiU has been awarded more than SEK 15 million by the Swedish Research Council to evaluate vaccination against Covid-19.

Publications

Latest publications in LiU DiVA

2025

Elin Folkesson, Gabrielle Froberg, Christopher Sundling, Thomas Schön, Erik Sodersten, Judith Bruchfeld (2025) Improved Detection of Extrapulmonary and Paucibacillary Pulmonary Tuberculosis by Xpert MTB Host Response in a Tuberculosis Low-Endemic, High-Resource Setting Journal of Infectious Diseases (Article in journal) Continue to DOI

2024

Johanna Kuhlin, Lina Davies Forsman, Aisha Osman, Magdalena Skagerberg, Jerker Jonsson, Ramona Groenheit, Mikael Mansjo, Jim Werngren, Jan-Willem Alffenaar, Thomas Schön, Judith Bruchfeld (2024) Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis International Journal of Antimicrobial Agents, Vol. 64, Article 107302 (Article in journal) Continue to DOI
Claudio U. Koeser, Paolo Miotto, Nabila Ismail, Richard M. Anthony, Christian Utpatel, Matthias Merker, Stefan Niemann, Sabira Tahseen, Leen Rigouts, Camilla Rodrigues, Shaheed V. Omar, Maha R. Farhat, Uladzimir Antonenka, Harald Hoffmann, Daniela M. Cirillo, Thomas Schön (2024) A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for Mycobacterium tuberculosis complex European Respiratory Journal, Vol. 64, Article 2400391 (Article in journal) Continue to DOI
J. E. Phelan, C. Utpatel, N. Ismail, T. Cortes, S. Niemann, D. M. Cirillo, Thomas Schön, P. Miotto, C. U. Koser (2024) Careful classification of potential bedaquiline resistance mutations is critical when analysing their clinical impact The International Journal of Tuberculosis and Lung Disease, Vol. 28, p. 312-313 (Article in journal) Continue to DOI
Armin Spreco, Örjan Dahlström, Dennis Nordvall, Cecilia Fagerstrom, Eva Blomqvist, Fredrik Gustafsson, Christer Andersson, Rune Sjödahl, Olle Eriksson, Jorma Hinkula, Thomas Schön, Toomas Timpka (2024) Integrated Surveillance of Disparities in Vaccination Coverage and Morbidity during the COVID-19 Pandemic: A Cohort Study in Southeast Sweden Vaccines, Vol. 12, Article 763 (Article in journal) Continue to DOI

Research

A doctor looks at X-rays.

Individualised diagnosis and treatment of tuberculosis

Our general aim is to individualise and thereby optimize management of clinical TB by new methods and strategies. The research group consists of specialists in tuberculosis from different professions.

Organisation

Teaser image for the division II at BKV.

Division of Inflammation and Infection (II)

The Division of Inflammation and Infection (II) includes clinical subject areas such as Immunology, Rheumatology, Pathology and Microbiology.

Department of Biomedical and Clinical Sciences (BKV)

What characterizes the Department of Biomedical and Clinical Sciences (BKV) is the wide breadth of research and education. BKV is one of the largest departments at LiU with affiliation mainly to the Faculty of Medicine and Health Sciences.

Tags